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SprX-N315        ACACAUGCAUCAACUAUUUACAUC----CUUGUUCACCCAAGCAUGUCACUGGGUGUUUU 56 
SprX1-HG001      ACACAUGCAUCAACUAUUUACAUCUAUCCUUGUUCACCCAAGCAUGUCACUGGGUGUUUU 60 
SprX2-HG001      ACACAUGCAUCAACUAUUUACAUCUAUCCUUGUUCACCCAAGCAUGUCACUGGGUGUUUU 60 
                 ************************    ******************************** 
 
SprX-N315        UUCUUAUGAUAGAGAGCAUAGUUUUCAUACUACUCCCCCGUAGUAUAUAUGACUUUAGCA 116 
SprX1-HG001      UUCUUAUGAUAGAGAGCAUAGUUUUCAUACUACUCCCUCGUAGUAUAUAUGACUUUAGCA 120 
SprX2-HG001      UUCUUACGAUAGAGAGCAUAGUUUUCAUACUACUCCC-CGUAGUAUAUAUGACUUUAGCA 119 
                 ****** ****************************** ********************** 
 
SprX-N315        UUCCCGUAUAAUAGUUUACGGGGUGCUUUUU 147 
SprX1-HG001      UUCCCGUAUAAUAGUUUACGGGGUGCUUUUU 151 
SprX2-HG001      UUCCCGUAUAACAGUUUACGGGGUGCUUUUU 150 
                 *********** ******************* 
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Supplementary Figure S1. Genomic location and sequence alignments of sprX. (A) 
Schematic representations of the genetic organization of the S. aureus sprX1 and sprX2 loci 
from strain HG001. The ORFs, sprX genes and nucleotide (nts) numbers correspond to those 
of strain HG001. (B) Alignments of the nucleotide sequences of SprX from strain N315 and 
the two SprX copies from strain HG001. Identical nucleotides in the sequences are indicated 












































Supplementary Figure S2. SprX modulates S. aureus glycopeptide resistance in VISA 
strain Mu50. (A) Upper panel: Northern blots showing SprX expression when grown until 
the late-exponential-phase in the Mu50 (wt) strain, Mu50 transformed by either pCN38 (wt 
pCN38) or by pCN38-sprX (wt pCN38-sprX). Lower panel: tmRNA used as a loading 
control. (B) Effect of SprX measured by agar plate assay in the presence of Teicoplanin. 
Overnight cultures were prepared in BHI of wt Mu50 strain transformed by either pCN38 (wt 
pCN38) or by pCN38-sprX (wt pCN38-sprX). Tenfold serial dilutions of cultures were 
deposited from top (most concentrated: 107 bacteria) to bottom (100 bacteria) on Mueller-
Hinton (MH) plates and on MH plates supplemented with either Teicoplanin. (C) Evaluation 
of the levels of resistance of Mu50 transformed by pCN38 (wt pCN38) and wt Mu50 
transformed by pCN38-sprX (wt pCN38-sprX) on gradient plate containing Teicoplanin. 
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Supplementary Figure S3. Coomassie stained gel loading controls. (A) Samples 
presented in Figure 2A, panel A. (B) Samples presented in Figure 6. Gels indicated that 
identical protein amounts were loaded for the HG001 wt (wt) and HG001∆sprX (∆sprX) 
and in HG001∆sprX transformed by either pCN38 (∆sprX pCN38), pCN38-sprX (∆sprX 















Supplementary Figure S4. SprX inhibits SpoVG protein expression during growth. (A) 
Western blot of SpoVG protein levels when grown until the early- (OD600 1) and late-
exponential (OD600 8) phases of growth in the wt HG001 strain (wt) and HG001∆sprX 


























Supplementary Figure S5. Effect of SprX on yabJ and yabJ-spoVG mRNAs expression 
levels. (A) Schematic representation of yabJ-spoVG mRNA. ORFs, mRNA lengths and the 
probe used for detection by Nothern blots of yabJ and yabJ-spoVG mRNAs are indicated. nts, 
nucleotides. (B) Northern blots were used to detect expression levels of yabJ and the yabJ-
spoVG mRNAs in strain HG001 wt (wt) and HG001∆sprX (∆sprX) and in HG001∆sprX 
transformed by either pCN38 (∆sprX pCN38) or pCN38-sprX (∆sprX pCN38-sprX). These 
were grown until 7.5 hours of growth. Probe against tmRNA was used as a loading control 
(probes are listed in Table II). (C) Northern blot quantification of the levels of yabJ and yabJ-
spoVG mRNAs of the strains from panel C. mRNA expression levels were calculated relative 
to the value measured for the wt strain. The error bars are the mean values derived from three 
independent experiments with independent RNA purifications. The tmRNA was used for 
normalization. The value of the mRNA levels in wild-type strain was normalized to 1. AU, 











































































































































Supplementary Figure S6. An alternative conformation for SprX (strain N315) was 
proposed based on the probing data. (A) 3’-labeled SprX was probed by RNase V1 (which 
cleaves double-strands or stacked nucleotides) and by nuclease S1 and lead acetate (which 
both cleave the accessible single-strands). Lanes are as follows: C, control; S1, Nuclease S1; 
V1, RNase V1; Pb, lead-induced cleavages; G, RNase T2;  A, RNase U2; and AH, alkaline 
ladders. SprX numbering is shown on the right. (B) Secondary structure of SprX from strain 
N315 based on probing data. The nucleotide numbering corresponds to SprX2 from HG001 
(Supplementary Figure S1). The mutated nucleotides in SprX_mutL3 are outlined on the 
SprX secondary structure model. Enzymatic cleavages are as follows: moderate ( ) and 
strong ( ) S1 Nuclease cleavages; ( ) lead(II)-cleavages; moderate ( ) and strong ( ) 









Supplementary Figure S7. SprX affects the Oxacillin sensibility of S. aureus strain 
HG001. Evaluation of the levels of resistance of the wt HG001 strain (wt); HG001∆sprX 
(∆sprX); wt HG001 transformed by pCN38 (wt pCN38); and wt HG001 transformed by 
pCN38-sprX (wt pCN38-sprX) on a gradient plate containing Oxacillin.
Table S1. Strains and plasmids used in this study. 
Strains Relevant characteristics References 
E. coli strains    
DH5a F- φ80d lacZ∆M15 D(lacZA-argF)U169 deoR recA1 endA1 hsdR17 (rK- 
mK-) phoA supE44 l- thi-1 gyrA96 relA1 
Invitrogen 
BL21 (D3) F- ompT gal dcm lon hsdSB (rB- mB-) (DE3) Novagen 
   
S.aureus strains   
HG001 rsbU restored strain 8325, lysogenic for phages φ11, φ12, and φ13  (1) 
HG001∆sprX HG001 deleted for sprX1 and sprX2 genes This study 
HG001∆yabJ-spoVG::erm HG001 deleted for yabJ-spoVG::erm(B); Emr This study 
RN4220 Restriction-defective derivative of 8325-4 (2) 
RN4220∆yabJ-spoVG::erm RN4220 deleted for yabJ-spoVG::erm(B); Emr (3) 
Mu50 VISA clinical isolate (4) 
   
Plasmids   
pCN38 Low-copy-number shuttle vector with Ampr in E. coli and Cmr in S. 
aureus 
(5) 
pCN38-sprX pCN38 with sprX copy 2 of HG001 under the control of its endogenous 
promoter 
This study 
pCN38-sprX_mutL3 pCN38 with mutated C-rich loop L3 of sprX2 under the control of its 
endogenous promoter 
This study 
pBT2 Low-copy-number shuttle vector with Ampr in E. coli and temperature 
sensitive replication with Cmr in S. aureus 
(6) 
pBT2∆sprX1 pBT2 vector containing the 1028-bp upstream genomic sequence of sprX 
copy 1 of HG001 and its 981-bp downstream sequence  
This study 
pBT2∆sprX2 pBT2 vector containing the 1050-bp upstream genomic sequence of sprX 
copy 2 of HG001 and its 948-bp downstream sequence 
This study 
pET-28a(+) Expression vector; Kmr  Novagen 
pSTM33 pET-28a(+) with 0.33-kb fragment covering spoVG; Kmr (3) 
a Abbreviations: Ampr, ampicillin resistant; Emr, erythromycin resistant; Cmr : Chloramphenicol resistant; Kmr, 
kanamycin resistant. 
  
Table S2. Primers used in this study. 
DNAs Sequences Purposes 
anti-C2 TACGGGAATGCTAAAGTCAT SprX Northern  
oSTM29 GCGTCGACTTATTGCAAATGTATTACATCGC yabJ-spoVG 
Northern 
oSTM30 CTAAATAA AACAGAGAGA TATATACTATAGG  
5S CGTAAGTTCGACTACCATCG 5S Northern 
tmRNA ACACGCTTAATGAGCTCGGG tmRNA Northern 
5'PSTI_sprX2 TTAAATCTGCAGTATTTACTTAGAATAAAAATTTTGC pCN38-sprX2 
3'EcoRI_sprX2 CAAAGGAATTCATTTCCACCTCTTTTAACACA  
mut for AGCATAGTTTTCATACTAGAGTAAGCTAGTATATATGACTTTAG pCN38-sprX_mutL3 
mut rev CTAAAGTCATATATACTAGCTTACTCTAGTATGAAAACTATGCT  
T7SprXfor TAATACGACTCACTATAGGGACACATGCATCAACTATTTAC sprX-N315 and 
sprX1 transcription 
T7SprXRev2A AAAGCACCCCGTAAACTATTAT  
T7SprXRev2B AAAGCACCCCGTAAACTGTTAT sprX2 transcription 
T7yabJ-spoVGfor TAATACGACTCACTATAGGGGTAGAATCAAAAGAAGTTAAAC yabJ-spoVG 
transcription 
T7yabJ-spoVGrev AATACGAGCATCATTCAAACGCA  
T7spoVGfor TAATACGACTCACTATAGGGGCTCACTACATGAAAGTGACA spoVG transcription 
fragSpoVGfor  TAATACGACTCACTATAGGGAATTATAATTTTCGATTAATA yabJ-spoVG167 
transcription 
fragSpoVGrev AAAGCTTCATCTAATGTAATGG  
Toeprint spoVG CAATTACACGTAAATCATGAAT spoVG toeprint 
Toeprint yabJ GTCCATCAATATTCAATGGAA yabJ toeprint 
sprXD1 ATCGGATATCGGATCCATAATGAGTGGATATGGCATGA sprX1 deletion  
sprXD6  ATCGTAAGCTTCTGCAGTCCTACAAATGAAGAAATAGAATC  




2sprXD1 TTACGAAGCTTGGATCCATCCGTAAATATATAACACCAAAT sprX2 deletion 








Table S3. Summary of the data collected by the DiGE analysis. 2D-DiGE performed on strain 
HG001 wt versus isogenic HG001 ∆sprX strain. Cultures were grown until the late 
exponential phase, when total proteins were extracted, labeled with different cyanine-dyes, 
and separated onto pH 4-7 acrylamide gels. The ratios correspond to the quantification 
obtained for the HG001∆sprX versus the wt strain (the data were collected in four different 
experiments). 
protein name Fold changes (HG001∆sprX/HG001 wt) 
HYP protein SAV0170 1.4 
UPF0356 protein USA300HOU_1032 1.3 
Putative septation protein SpoVG 1.4 
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